About Aurora
Expertise where science meets finance
Aurora Bio Partners combines deep life sciences expertise with practical funding experience to help innovative Australian companies navigate complex financing decisions.
Founded by Holly Stefl, Aurora partners with biotechnology, medtech and clinical diagnostics companies to identify non-dilutive capital solutions that preserve equity, enhance financial flexibility, and accelerate clinical development.
OUR APPROACH
Every funding strategy starts with understanding the challenge
Every company is different. We take the time to understand your scientific, commercial and funding objectives before identifying the right capital pathway.
how we help
Scientific and funding solutions tailored to your stage of growth
Whether you're advancing preclinical research, entering clinical trials or preparing for commercialisation, Aurora helps connect companies with the right capital at the right time.
Strategic capital advisory
Non-dilutive funding strategy
Grant funding solutions
Drug development guidance
Why CHOOSE Aurora
Trusted expertise
Practical advice
20+ years across drug development
Fast, practical and transparent approach
Extensive network of capital partners and industry specialists
Tailored funding strategies, not one-size-fits-all solutions
Australian owned
EXPERIENCE MATTERS
Holly Stefl
Founder & Director
With more than two decades of experience across life sciences, drug development and specialist R&D financing, Holly has built a reputation for helping innovative preclinical and clinical-stage biotechs, medtechs and clinical diagnostics access non-dilutive capital with certainty and timely execution.
Aurora Bio Partners was established to provide Australian life sciences companies with independent, practical advice and tailored non-dilutive funding solutions that accelerate development while preserving shareholder value.
Holly works closely with founders, executive teams and investors to identify funding strategies that support long-term growth while allowing companies to stay focused on advancing innovation.
CONTACT
Let's start the conversation
Whether you are exploring non-dilutive funding options or planning your next stage of growth in Australia, we welcome the opportunity to hear from you and understand your objectives.
✉ hello@aurorabiopartners.com
✆ +61 466 947 174
⚲ Sydney, Australia